← Leaderboards
Gregory A Cox
Jackson Laboratory
$11,518,159
Attributed
$16,246,412
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,246,412 · 9
By mechanism
R01$13,269,462 · 4
R21$1,446,472 · 3
R25$1,215,590 · 1
T32$314,888 · 1
Top collaborators
- Claudio A.P. Joazeiro9 shared
- Robert W Burgess7 shared
- David L Valle5 shared
- Carol J Bult2 shared
- Kevin L Seburn2 shared
- Clarissa A Henry1 shared
- Lucy Liaw1 shared
Most similar at Jackson Laboratory
Same institution · by research overlap
- Robert W Burgess$21,511,737
- Carol J Bult$70,917,571
- Kevin L Seburn$944,808
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesHuman DiseaseProteinsPhenotypeMutationPathway InteractionsMutantMouse ModelGeneticLeadMolecularDefectAffectLinkPlayCellsBasic ScienceFunctional DisorderNervous System DisorderDisease ProgressionComplexFundingMotor NeuronsResources
Grant awards (43)
Polyalanine Tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$735,524
R01 · FY2025 · NS
T32 for GSBSE$314,888
T32 · FY2025 · GM
Polyalanine Tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$717,158
R01 · FY2024 · NS
Polyalanine Tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$732,174
R01 · FY2023 · NS
Human and Mammalian Genetics and Genomics: the McKusick Short Course$152,938
R25 · FY2023 · HD · contact PI
Polyalanine Tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$751,212
R01 · FY2022 · NS · contact PI
Human and Mammalian Genetics and Genomics: the McKusick Short Course$152,938
R25 · FY2022 · HD · contact PI
CAT-tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$662,384
R01 · FY2021 · NS · contact PI
Human and Mammalian Genetics and Genomics: the McKusick Short Course$151,318
R25 · FY2021 · HD · contact PI
CAT-tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$662,384
R01 · FY2020 · NS · contact PI
Human and Mammalian Genetics and Genomics: the McKusick Short Course$151,318
R25 · FY2020 · HD · contact PI
CAT-tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$659,497
R01 · FY2019 · NS · contact PI
Human and Mammalian Genetics and Genomics: the McKusick Short Course$151,318
R25 · FY2019 · HD · contact PI
CAT-tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$659,497
R01 · FY2018 · NS · contact PI
Short Course on Medical and Experimental Mammalian Genetics$113,940
R25 · FY2018 · HD · contact PI
CAT-tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$678,247
R01 · FY2017 · NS · contact PI
Short Course on Medical and Experimental Mammalian Genetics$113,940
R25 · FY2017 · HD · contact PI
Genetic Control of Phospholipid Biosynthesis and Muscular Dystrophy$533,530
R01 · FY2016 · AR · contact PI
Short Course on Medical and Experimental Mammalian Genetics$113,940
R25 · FY2016 · HD · contact PI
Genetic Control of Phospholipid Biosynthesis and Muscular Dystrophy$533,530
R01 · FY2015 · AR · contact PI
Short Course on Medical and Experimental Mammalian Genetics$113,940
R25 · FY2015 · HD · contact PI
Genetic Control of Phospholipid Biosynthesis and Muscular Dystrophy$522,860
R01 · FY2014 · AR · contact PI
Imaging Circuit Change in the Motor Cortex of Mouse Model of ALS$259,875
R21 · FY2014 · NS · contact PI
Metabolite Profiling of a Novel Mitochondrial Kinase in Neuromuscular Disease$216,563
R21 · FY2014 · NS
Genetic Control of Phospholipid Biosynthesis and Muscular Dystrophy$506,853
R01 · FY2013 · AR · contact PI
Metabolite Profiling of a Novel Mitochondrial Kinase in Neuromuscular Disease$262,500
R21 · FY2013 · NS
Imaging Circuit Change in the Motor Cortex of Mouse Model of ALS$218,750
R21 · FY2013 · NS · contact PI
Genetic Control of Phospholipid Biosynthesis and Muscular Dystrophy$552,280
R01 · FY2012 · AR · contact PI
Genetic Control of Phospholipid Biosynthesis and Muscular Dystrophy$332,572
R01 · FY2011 · AR · contact PI
A Spontaneous Mouse Model of Motor Neuron Disease$264,159
R21 · FY2011 · NS
Genetic Control of Phospholipid Biosynthesis and Muscular Dystrophy$346,432
R01 · FY2010 · AR · contact PI
A Spontaneous Mouse Model of Motor Neuron Disease$224,625
R21 · FY2010 · NS
Genetic Control of Phospholipid Biosynthesis and Muscular Dystrophy$349,931
R01 · FY2009 · AR · contact PI
Genetic Control of Phospholipid Biosynthesis and Muscular Dystrophy$349,931
R01 · FY2008 · AR · contact PI
Genetic Control of Phospholipid Biosynthesis and Muscular Dystrophy$411,032
R01 · FY2007 · AR · contact PI
Genetic Mechanisms of Muscular Dystrophy in Mice$363,201
R01 · FY2007 · AR · contact PI
Genetic Mechanisms of Muscular Dystrophy in Mice$374,049
R01 · FY2006 · AR · contact PI
Genetic Mechanisms of Muscular Dystrophy in Mice$383,050
R01 · FY2005 · AR
Genetic Mechanisms of Muscular Dystrophy in Mice$383,050
R01 · FY2004 · AR
Genetic Mechanisms of Muscular Dystrophy in Mice$383,050
R01 · FY2003 · AR
GENETIC CONTROL OF NEUROMUSCULAR DEGENERATION IN MICE$235,470
R01 · FY2002 · NS
GENETIC CONTROL OF NEUROMUSCULAR DEGENERATION IN MICE$228,611
R01 · FY2001 · NS
GENETIC CONTROL OF NEUROMUSCULAR DEGENERATION IN MICE$221,953
R01 · FY2000 · NS